- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 28-01-2026: Press Release
28-01-2026 | 08:46 am
28-01-2026 | 08:46 am
Biocon Biologics' credit rating upgraded to ‘BB+’ by S&P Global, outlook “Stable.” This follows capital structure simplification, settling US$1 billion CCPS. Adjusted debt to decline to ~11,500 Cr and FFO to debt to reach 30% by fiscal 2027, boosted by new products.
No comments yet. Be the first to comment!